Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Music therapy significantly improves cognitive functions like memory and language in older adults with Alzheimer's disease (AD). This non-pharmacological approach also enhances patient-specialist connections.
Area Of Science
- Neuroscience
- Gerontology
- Psychiatry
Background
- Alzheimer's disease (AD) is a progressive dementia affecting 50 million globally, with no cure.
- Current treatments focus on symptom management through pharmacological and non-pharmacological methods.
- Music therapy shows promise as musical abilities are often preserved in AD patients.
Purpose Of The Study
- To systematically review the benefits of music therapy for cognitive impairments in elderly individuals with AD.
- To assess the impact of music interventions on cognitive function in Alzheimer's patients.
Main Methods
- Systematic review adhering to PRISMA guidelines.
- Searches conducted in PubMed, SCOPUS, Cochrane Library, and Dialnet (2010-2024).
- Included randomized controlled trials and clinical trials in English/Spanish involving AD patients (≥65 years) and music interventions.
Main Results
- Eleven studies were included, indicating music therapy improved memory, language, and orientation.
- Methodological quality analysis revealed six studies with good and four with excellent quality.
- Music therapy demonstrated positive effects on cognitive domains in Alzheimer's patients.
Conclusions
- Music therapy is an effective treatment for improving cognitive impairments in Alzheimer's disease patients.
- Music interventions foster a crucial connection between patients and healthcare specialists.
- Further research supports music therapy as a valuable non-pharmacological intervention for AD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...